Pharmaceutical Product Development (United States)

About

In recent decades, authors affiliated with Pharmaceutical Product Development (United States) have published 880 papers, which have received a total of 29.9k indexed citations. Scholars at this organization have produced 274 papers in Molecular Biology, 84 papers in Immunology and 81 papers in Pulmonary and Respiratory Medicine on the topics of Protein purification and stability (96 papers), Monoclonal and Polyclonal Antibodies Research (65 papers) and Genetic and Kidney Cyst Diseases (58 papers). Their work is cited by papers focused on Molecular Biology (11.1k citations), Radiology, Nuclear Medicine and Imaging (3.5k citations) and Genetics (3.4k citations). Authors at Pharmaceutical Product Development (United States) collaborate with scholars in United States, United Kingdom and Japan and have published in prestigious journals including Nature, New England Journal of Medicine and Journal of the American Chemical Society. Some of Pharmaceutical Product Development (United States)'s most productive authors include Robert S. Wallis, Steven J. Shire, Frank S. Czerwiec, Carole W. Cranor, Dale B. Christensen, Alla Danilkovitch‐Miagkova, John Ouyang, Vicente E. Torres, Berton Zbar and Arlene B. Chapman.

In The Last Decade

Pharmaceutical Product Development (United States)

844 papers receiving 29.7k citations

Fields of papers published by authors at Pharmaceutical Product Development (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Pharmaceutical Product Development (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Pharmaceutical Product Development (United States) at the time of their publication.

Countries citing scholars working at Pharmaceutical Product Development (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Pharmaceutical Product Development (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pharmaceutical Product Development (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pharmaceutical Product Development (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026